Characteristics and Outcomes of Gastrointestinal Manifestations of COVID-19

Assiut University

Status: Unknown

Conditions: Infectious

Treatments: Diagnostic Test: Laboratory tests

Study type: Observational

Funder types: Other

Identifiers

NCT04490772

COVID gastro intestinal

Details and patient eligibility

About

Patients confirmed COVID-19 with gastrointestinal manifestations will be included. Characteristics and outcomes will be described for them.

Full description

Patients diagnosed as confirmed Covid-19 according to WHO and Egyptian Ministry of Health and Population (MOH) definitions will be included.The following will be done for all patients:

Demographic characters; age, sex, presence of co-morbidities such as hypretension, diabetes mellitus, obstructive lung diseases, ischemic heart diseases...etc, history of contact to covid-19 patients or recent travelling abroad.Clinical Characteristics: By recording of clinical manifestation such as fever, cough, shortness of breath, sore throat, change in taste or smell, nausea,vomiting and diarrhea will be done. Complications and the type of treatment received by the patients will also be described including mechanical ventilation.

Laboratory data will also be included : blood picture, liver enzymes, ESR,CRP, serum ferritin, D-dimer and troponin.

Follow up of the patients will be done until improvement, deaths or complications to determine disease outcomes.

Enrollment: 200 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Confirmed Covid-19 with GIT manifestations

Exclusion criteria

• Patients refuse to participate

Trial design

200 participants in 1 patient group

Patients with Covid-19

Description:

COVID-19 patients presented with gastrointestinal manifestations

Treatment:

Diagnostic Test: Laboratory tests